Overview
Xiaoqian Zhai practices in Chengdu, China. Zhai is rated as an Advanced expert by MediFind in the treatment of Lung Adenocarcinoma. Their top areas of expertise are Lung Adenocarcinoma, Metastatic Pleural Tumor, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).
Their clinical research consists of co-authoring 30 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 8 articles in the study of Lung Adenocarcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung AdenocarcinomaZhai isAdvanced. Learn about Lung Adenocarcinoma.
- Metastatic Pleural Tumor
- Experienced
- EGFR Positive Lung CancerZhai isExperienced. Learn about EGFR Positive Lung Cancer.
- Familial Prostate CancerZhai isExperienced. Learn about Familial Prostate Cancer.
- Lung CancerZhai isExperienced. Learn about Lung Cancer.
- Lung NodulesZhai isExperienced. Learn about Lung Nodules.
- Non-Small Cell Lung Cancer (NSCLC)
- Pleural EffusionZhai isExperienced. Learn about Pleural Effusion.